Edition:
United States

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

2.12USD
18 Aug 2017
Change (% chg)

$0.11 (+5.47%)
Prev Close
$2.01
Open
$2.03
Day's High
$2.25
Day's Low
$2.00
Volume
289,658
Avg. Vol
190,492
52-wk High
$8.22
52-wk Low
$1.20

ARWR.OQ

Chart for ARWR.OQ

About

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of... (more)

Overall

Beta: 1.79
Market Cap(Mil.): $158.52
Shares Outstanding(Mil.): 74.77
Dividend: --
Yield (%): --

Financials

  ARWR.OQ Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -0.67 -- --
ROI: -55.08 2.83 14.89
ROE: -61.13 5.09 16.13

BRIEF-Arrowhead Qtrly loss per share $0.07

* Qtrly revenue $9.3 million versus $39,583 Source text for Eikon: Further company coverage:

Aug 03 2017

BRIEF-Arrowhead reports Q2 revenue $9 million

* Q2 revenue $9 million versus $43,750 Source text for Eikon: Further company coverage:

May 03 2017

BRIEF-Arrowhead Pharmaceuticals adopts stockholder rights agreement

* Arrowhead Pharmaceuticals adopts stockholder rights agreement

Mar 23 2017

Earnings vs. Estimates